Looking Beyond the Glioblastoma Mask: Is Genomics the Right Path?

Looking Beyond the Glioblastoma Mask: Is Genomics the Right Path?

Glioblastomas are the most frequent and malignant brain tumor hallmarked by an invariably poor prognosis. They have been classically differentiated into primary isocitrate dehydrogenase 1 or 2 (IDH1 -2) wild-type (wt) glioblastoma (GBM) and secondary IDH mutant GBM, with IDH wt GBMs being commonly a...

Full description

Bibliographic Details
Main Authors: Liliana Montella, Nunzio Del Gaudio, Guglielmo Bove, Mariella Cuomo, Michela Buonaiuto, Davide Costabile, Roberta Visconti, Gaetano Facchini, Lucia Altucci, Lorenzo Chiariotti, Rosa Della Monica
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
glioblastoma
targeted therapy
EGFR
B-Raf
Met
NF-1
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.926967/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.926967/full

Similar Items